carnitine has been researched along with Dyskinesia Syndromes in 8 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 9-month-old patient was admitted with encephalopathy and acute loss of acquired motor skills during the course of COVID-19 disease." | 1.62 | COVID-19 triggered encephalopathic crisis in a patient with glutaric aciduria type 1. ( Ahmadzada, S; Aktuglu-Zeybek, C; Kiykim, E; Yalcinkaya, C; Zubarioglu, T, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Zubarioglu, T | 1 |
| Ahmadzada, S | 1 |
| Yalcinkaya, C | 1 |
| Kiykim, E | 1 |
| Aktuglu-Zeybek, C | 1 |
| Külkens, S | 1 |
| Harting, I | 1 |
| Sauer, S | 1 |
| Zschocke, J | 1 |
| Hoffmann, GF | 1 |
| Gruber, S | 1 |
| Bodamer, OA | 1 |
| Kölker, S | 1 |
| Silva-Adaya, D | 1 |
| Pérez-De La Cruz, V | 1 |
| Herrera-Mundo, MN | 1 |
| Mendoza-Macedo, K | 1 |
| Villeda-Hernández, J | 1 |
| Binienda, Z | 1 |
| Ali, SF | 1 |
| Santamaría, A | 1 |
| Samuraki, M | 1 |
| Komai, K | 1 |
| Hasegawa, Y | 1 |
| Kimura, M | 1 |
| Yamaguchi, S | 1 |
| Terada, N | 1 |
| Yamada, M | 1 |
| Elpeleg, ON | 1 |
| Ruitenbeek, W | 1 |
| Jakobs, C | 1 |
| Barash, V | 1 |
| De Vivo, DC | 1 |
| Amir, N | 1 |
| Prats Viñas, J | 1 |
| Corral, I | 1 |
| Martínez Castrillo, JC | 1 |
| Martínez-Pardo, M | 1 |
| Gimeno, A | 1 |
| Goety, CG | 1 |
| Tanner, CM | 1 |
| Cohen, JA | 1 |
| Thelen, JA | 1 |
| Carroll, VS | 1 |
| Klawans, HL | 1 |
| Fariello, RG | 1 |
1 trial available for carnitine and Dyskinesia Syndromes
| Article | Year |
|---|---|
L-acetyl-carnitine in Huntington's disease: double-blind placebo controlled crossover study of drug effects on movement disorder and dementia.
Topics: Acetylcarnitine; Adult; Aged; Carnitine; Dementia; Double-Blind Method; Female; Humans; Huntington D | 1990 |
7 other studies available for carnitine and Dyskinesia Syndromes
| Article | Year |
|---|---|
COVID-19 triggered encephalopathic crisis in a patient with glutaric aciduria type 1.
Topics: Amino Acid Metabolism, Inborn Errors; Brain; Brain Diseases; Brain Diseases, Metabolic; Carnitine; C | 2021 |
Late-onset neurologic disease in glutaryl-CoA dehydrogenase deficiency.
Topics: Age of Onset; Aged; Atrophy; Brain Diseases, Metabolic, Inborn; Carnitine; Cerebral Cortex; Cognitio | 2005 |
Excitotoxic damage, disrupted energy metabolism, and oxidative stress in the rat brain: antioxidant and neuroprotective effects of L-carnitine.
Topics: Animals; Antioxidants; Brain; Carnitine; Convulsants; Disease Models, Animal; Dose-Response Relation | 2008 |
A successfully treated adult patient with L-2-hydroxyglutaric aciduria.
Topics: Adult; Age Factors; Alcohol Oxidoreductases; Brain; Brain Diseases, Metabolic; Brain Diseases, Metab | 2008 |
Congenital lacticacidemia caused by lipoamide dehydrogenase deficiency with favorable outcome.
Topics: Acidosis, Lactic; Carnitine; Dichloroacetic Acid; Dihydrolipoamide Dehydrogenase; Fibroblasts; Human | 1995 |
[Glutaric aciduria type I: an organic acidemia without acidosis with severe movement disorders].
Topics: Adult; Amino Acid Metabolism, Inborn Errors; Brain Diseases, Metabolic; Carnitine; Child, Preschool; | 2001 |
[Glutaric aciduria type I: diagnosis in adulthood and phenotypic variability].
Topics: Adolescent; Adult; Amino Acid Metabolism, Inborn Errors; Brain; Brain Diseases, Metabolic; Carnitine | 2001 |